LeeYR, YehiaL, KishikawaT, NiY, LeachB, ZhangJ, PanchN, LiuJ, WeiW, EngC, PandolfiPP. 2020. WWP1 gain-of-function inactivation of PTEN in cancer predisposition. N Engl J Med, 382:2103–2116.
2.
MyersMP, StolarovJP, EngC, LiJ, WangSI, WiglerMH, ParsonsR, TonksNK. 1997. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA, 94:9052–9057.
3.
LiawD, MarshDJ, LiJ, DahiaPL, WangSI, ZhengZ, BoseS, CallKM, TsouHC, PeacockeM, EngC, ParsonsR. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet, 16:64–67.
4.
NagyR, GanapathiS, ComerasI, PetersonC, OrloffM, PorterK, EngC, RingelMD, KloosRT. 2011. Frequency of germline PTEN mutations in differentiated thyroid cancer. Thyroid, 21:505–510.
5.
NikiforovaMN, MercurioS, WaldAI, Barbi de MouraM, CallenbergK, Santana-SantosL, GoodingWE, YipL, FerrisRL, NikiforovYE. 2018. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer, 124:1682–1690.
